Free

E-Newsletters

Subscribe to receive the latest updates on health topics. About our newsletters

  • Housecall
  • Alzheimer's caregiving
  • Living with cancer

Causes

By Mayo Clinic staff

CLICK TO ENLARGE

Illustration of breast, including lymph nodes, lobules and ducts 
Breast anatomy

Living with cancer newsletter

Subscribe to our Living with cancer newsletter to stay up to date on cancer topics.

It's not clear what causes invasive lobular carcinoma.

How invasive lobular carcinoma forms
Doctors know that invasive lobular carcinoma begins when cells in one or more milk-producing glands of the breast develop mutations in their DNA. The mutations tell the cells to divide and grow rapidly. The cancer cells can spread to other parts of the body.

The earliest marker of abnormal cells within the lobule is a condition that's referred to as lobular carcinoma in situ (LCIS). Although the term includes the word "carcinoma," LCIS is not cancer. Instead, LCIS is considered an indicator of increased risk of breast cancer.

At some point, abnormal cells may break out of the lobules and invade or "infiltrate" the surrounding tissue, becoming invasive lobular carcinoma. Lobular carcinoma cells tend to break out of the lobule in single file, then invade surrounding breast tissue in a web-like manner. The affected area may have a different feel from normal breast tissue, but it is unlikely to feel like a lump.

References
  1. Hanby AM, et al. In situ and invasive lobular neoplasia of the breast. Histopathology. 2008;52:58.
  2. Katz A, et al. Primary systemic chemotherapy of invasive lobular carcinoma of the breast. Lancet Oncology. 2007;8:55.
  3. Abeloff MD, et al. Cancer of the breast. In: Abeloff MD, et al. Abeloff's Clinical Oncology. 4th ed. Philadelphia, Pa.: Churchill Livingstone; 2008:1875.
  4. Breast cancer. Fort Washington, Pa.: National Comprehensive Cancer Network. http://www.nccn.org/professionals/physician_gls/PDF/breast.pdf. Accessed Jan. 20, 2010.
  5. Biglia N, et al. Increased incidence of lobular breast cancer in women treated with hormone replacement therapy: Implications for diagnosis, surgical and medical treatment. Endocrine-Related Cancer. 2007;14:549.
  6. Pestalozzi BC. Portrait of invasive lobular carcinoma of the breast. European Journal of Cancer. 2009;45(suppl):450.
  7. Eheman CR, et al. The changing incidence of in situ and invasive ductal and lobular breast carcinomas: United States, 1999-2004. Cancer Epidemiology, Biomarkers & Prevention. 2009;18:1763.
  8. Mann RM, et al. MRI compared to conventional diagnostic work-up in the detection and evaluation of invasive lobular carcinoma of the breast: A review of the existing literature. Breast Cancer Research and Treatment. 2008;107:1.
  9. Schrader KA, et al. Hereditary diffuse gastric cancer: Association with lobular breast cancer. Familial Cancer. 2008;7:73.
  10. Breast cancer treatment (PDQ): Health professional version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/treatment/breast/healthprofessional/allpages/print. Accessed Feb. 16, 2010.
  11. Breast cancer prevention (PDQ): Health professional version. National Cancer Institute. http://www.cancer.gov/cancertopics/pdq/prevention/breast/healthprofessional/allpages/print. Accessed Feb. 16, 2010.
  12. Avis NE. Breast cancer survivors and hot flashes: The search for nonhormonal treatments. Journal of Clinical Oncology. 2008;26:5008.
  13. Polednak A. Bilateral synchronous breast cancer: A population-based study of characteristics, method of detection, and survival. Surgery. 2003;133:383.
  14. Goldflam K, et al. Contralateral prophylactic mastectomy: Predictors of significant histologic findings. Cancer. 2004;101:1977.
  15. Pruthi S (expert opinion). Mayo Clinic, Rochester, Minn. Dec. 9, 2010.
DS01063 Dec. 7, 2011

© 1998-2012 Mayo Foundation for Medical Education and Research (MFMER). All rights reserved. A single copy of these materials may be reprinted for noncommercial personal use only. "Mayo," "Mayo Clinic," "MayoClinic.com," "EmbodyHealth," "Enhance your life," and the triple-shield Mayo Clinic logo are trademarks of Mayo Foundation for Medical Education and Research.

Print Share Reprints

Advertisement


Text Size: smaller largerlarger